The use of digoxin was associated with a slightly improved survival but no difference in rate of rehospitalization in a new study based on a nationwide propensity-matched cohort of Danish patients with heart failure and atrial fibrillation (AF). Lead author Dr Christian Madelaire (Gentofte University Hospital, Copenhagen, Denmark) presented these findings in an oral session […]
A high-sensitivity troponin I test showed great accuracy in ruling out myocardial infarction (MI) in patients with chest pain, with triage times reduced to 1 hour, and also showed better positive predictive ability than some other studies.
A new analysis of the IMPROVE-IT trial indicates that the nonstatin, cholesterol-lowering drug ezetimibe (Zetia, Merck) is of specific benefit in patients with acute coronary syndrome who also have diabetes.
In patients with chronic Chagas cardiomyopathy (American trypanosomiasis), early therapy with benznidazole lowered the number of parasites in the blood but failed to slow long-term cardiac deterioration, researchers say.
Men with erectile dysfunction had more than double the odds of having undiagnosed diabetes, whereas no association was seen for undiagnosed hypertension or undiagnosed hypercholesterolemia.
According to a study, a common clinical risk score (CHA2DS2-VASc) predicted ischemic stroke, thromboembolism, and death among patients with heart failure with or without atrial fibrillation, but only modestly.
In a large cohort of Swedish men aged approximately 60 years old, those who walked or cycled at least 20 minutes a day had a 21% lower risk of having heart failure by the time they were about 73, researchers report.
It has reported an association between lower scores for executive function and an increased risk for stroke and coronary heart disease (CHD) that is independent of vascular risk factors such as hypertension and diabetes among elderly patients at increased risk for cardiovascular events but who are free from dementia.